Pfizer, BioNTech Submit COVID Vaccine Data To FDA For Kids 5-11

by

FILE - In this Jan. 22, 2021, file photo, a certified medical assistant prepares doses of the Pfizer COVID-19 vaccine at a vaccination center at the University of Nevada, Las Vegas. With more than 40 million doses of coronavirus vaccines available, U.S. health authorities said they're confident both seniors and other vulnerable Americans seeking booster shots and parents anticipating approval of initial shots for young children will have easy access. (AP Photo/John Locher, File)
Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on email
Reading Time: < 1 minute

Pfizer and BioNTech have submitted data to the FDA from trials of nearly 2300 participants aged 5-11.

Dr. Anthony Fauci suggests pending FDA approval, children will be eligible for COVID vaccines by the end of October.

What can we expect next for the fourth quarter? Listen to Ebony McMorris’ report.

Click ▶️ to listen to Ebony McMorris’s AURN News report:

AURN Facebook Feed

advanced divider
advanced divider
Advertisement

AURN NEWS WITH EBONY MCMORRIS